🇬🇧·5d agoResearch
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS G12D -mutant pancreatic cancer: a phase 1b/2 trial
Publisher
N
Nature Medicine
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Nature Medicine
- Region
- UK
- Scope
- Research
- Published
- July 9, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: Nature Medicine
Scope: Research
Related coverage
More related coverage
Northwestern Medicine/4h ago
Northwestern Medicine performs first known quadruple-organ transplant involving retransplanted lungs
Universitätsklinikum Heidelberg/5h ago
138 Doktorurkunden, vier Stiftungspreise und ein Nobelpreisträger
Hospital ClĂnic de Barcelona/6h ago
A study identifies a relationship between cognitive reserve and brain structure in young people at risk of psychosis
UNMC/7h ago